The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype

European Journal of Endocrinology

Volumn 158, Issue 6, 2008, Pages 861-865

  Xita, Nectaria ^a   Georgiou, Ioannis ^a   Lazaros, Leandros ^a   Psofaki, Vasiliki ^b   Kolios, George ^b   Tsatsoulis, Agathocles ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AROMATIZATION; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA EXTRACTION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD; GENETIC POLYMORPHISM; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANDROGENS; AROMATASE; BASE SEQUENCE; BODY MASS INDEX; ESTRADIOL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN RESISTANCE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 44949233161     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/EJE-07-0905     Document Type: Article

References (26)

1. Legro RS, Driscoll D, Fox J III, Strauss JF & Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. PNAS 1998 95 14956-14960.
2. Abbott DH, Dumesic DA & Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. Journal of Endocrinology 2002 174 1-5.
3. Xita N & Tsatsoulis A. Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. Journal of Clinical Endocrinology and Metabolism 2006 91 1660-1666.
4. Xita N, Tsatsoulis A, Chatzikyriakidou A & Georgiou I. Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG levels. Journal of Clinical Endocrinology and Metabolism 2003 88 5976-5980.
5. Cousin P, Calemard-Michel L, Lejeune H, Raverot G, Yessaad N, Emptoz-Bonneton A, Morel Y & Pugeat M. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women. Journal of Clinical Endocrinology and Metabolism 2004 89 917-924.
6. Ferk P. Teran N & Gersak K. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome. Human Reproduction 2007 22 1031-1036.
7. Turk A, Kopp P, Colangelo LA, Urbanek M, Wood K, Liu K, Skinner HG & Gapstur SM. Associations of serum sex hormone-binding globulin (SHBG) levels with SHBG gene polymorphisms in the CARDIA Male Hormone Study. American Journal Epidemiology 2007 167 412-418.
8. Ito Y, Fisher CR, Conte FA, Grumbach MM & Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. PNAS 1993 90 11673-11677.
9. Belgorosky A, Pepe C, Marino R, Guercio G, Saraco N, Vaiani E & Rivarola MA. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two now point mutations of the CYP19 gone. Journal of Clinical Endocrinology and Metabolism 2003 88 5127-5131.
10. Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS, McCarthy M, Franks S & Williamson R. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Human Molecular Genetics 1997 6 397-402.
11. Urbanck M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF III, Spielman RS & Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. PNAS 1999 96 8573-8578.
12. Soderlund D, Canto P, Carranza-Lira S & Mendez JP. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome. Human Reproduction 2005 20 965-969.
13. Petry CJ, Ong KK, Michelmore KF, Artigas S, Wingate DL, Balen AH, de Zegher F, Ibanez L & Dunger DB. Association of aromatase (CYP19) gene variation with features of hyperandro-genism in two populations of young women. Human Reproduction 2005 20 1837-1843.
14. Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G & Bjorntorp P. The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obesity Research 2003 11 578-585.
15. Zawadzki JK & Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Polycystic Ovary Syndrome, pp 377-384. Eds A Dunaif, JR Givens, F Haseltine & GR Merriam, Boston: Blackwell, 1992.
16. Clark AF, Marcellus S, deLory B & Bird CE. Plasma testosterone free index: a better indicator of plasma androgen activity? Fertility and Sterility 1975 26 1001-1005.
17. Legro RS, Finegood D & Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1998 83 2694-2698.
18. Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Karesen R, Kristensen T & Borresen-Dale AL. Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 2000 19 1329-1333.
19. Gennari L, Masi L, Merlotti D, Picariello L, Falchetti A, Tanini A, Mavilia C, Del Monte F, Gonnelli G, Lucani B, Gennari C & Brandi ML. A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. Journal of Clinical Endocrinology and Metabolism 2004 89 2803-2810.
20. Gabrilove JL. The pathogenesis of the polycystic ovary syndrome: a hypothesis. Endocrine Practice 2002 8 127-132.
21. Short RV & London DR. Defective biosynthesis of ovarian steroids in the Stein-Leventhal syndrome. BMJ 1961 1 1724-1727.
22. Gabrilove JL. Diseases associated with some enzymic defects in the gonads and adrenal cortex; a classification based on a theory of the biogenesis of the feminizing and virilizing syndromes. Journal of the Mount Sinai Hospital, New York 1964 31 449-456.
23. Grumbach MM & Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. Journal of Clinical Endocrinology and Metabolism 1999 84 4677-4694.
24. Bulun SE. Clinical Review 78: aromatase deficiency in women and men; would you have predicted the phenotypes? Journal of Clinical Endocrinology and Metabolism 1996 81 867-871.
25. Ehrmann DA, Barnes RB & Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocrine Reviews 1995 16 322-353.
26. Britt KL & Findlay JK. Estrogen actions in the ovary revisited. Journal of Endocrinology 2002 175 269-276.